Rate My Professor Ed Wilson

Professor Ed Wilson holds the position of Professor of Health Economics and Health Policy at the University of Exeter, within the Public Health and Sport Sciences department of the University of Exeter Medical School. He is the Director of the Peninsula Technology Assessment Group (PenTAG), an academic group that serves as an external assessment group for the National Institute for Health and Care Excellence (NICE), undertaking health technology assessments including single technology appraisals, highly specialised technology evaluations, and diagnostics assessments. Under his leadership, PenTAG has contributed to numerous NICE submissions, such as the appraisals for seladelpar in primary biliary cholangitis (2025), vadadustat for anaemia (2024), vamorolone for Duchenne muscular dystrophy (2024), etranacogene dezaparvovec for haemophilia B (2024), and compression products for venous leg ulcers (2024), among others. Wilson brings over 25 years of expertise in economic evaluation and decision modelling, having previously held academic posts at the Universities of York, Cambridge, and East Anglia, with brief stints in industry.

Wilson's primary research interests encompass decision analytic modelling, expert elicitation techniques for parameterizing models amid limited data, and value-of-information analyses to guide research prioritization. He has authored more than 100 peer-reviewed journal articles and book chapters, garnering over 6,500 citations on Google Scholar and more than 21,000 on ResearchGate. Key publications include 'Are brief interventions to increase physical activity cost-effective? A systematic review' (with V. Gc et al.) and contributions to NICE technology appraisal reports. He serves as a member of NICE's Highly Specialised Technologies Appraisal Committee. In 2025, Wilson secured a £6.5 million UK Research and Innovation (UKRI) grant to lead the UK Hub for One Health Systems, partnering with institutions like Queen's University Belfast and NHS trusts to develop sustainable pathways for health and social care towards net-zero emissions. He delivered his University of Exeter Medical School inaugural lecture in January 2025 on health technology assessment topics. His contributions significantly shape UK health policy through evidence-based economic analyses.